winterspr
season
patient
acut
respiratori
infect
associ
human
coronaviru
hcov
strain
identifi
among
immunocompet
immunocompromis
patient
admit
hospit
acut
respiratori
syndrom
viral
infect
diagnos
either
immunolog
monoclon
antibodi
molecular
rtpcr
method
two
set
primer
pair
develop
detect
cov
pancov
fail
detect
hcov
strain
identifi
hand
hcov
strain
could
detect
use
typespecif
primer
target
gene
n
cell
line
found
suscept
isol
identif
strain
overal
hcov
infect
caus
strain
patient
respect
addit
three
patient
infect
untyp
hcov
strain
strain
found
circul
strain
circul
strain
detect
season
monthli
distribut
reach
peak
januari
march
lower
predomin
upper
respiratori
tract
infect
age
group
addit
hcov
infect
interest
immunocompet
infant
young
children
first
year
life
adult
immunocompromis
patient
coinfect
hcov
respiratori
virus
mostli
interest
first
year
life
observ
patient
associ
sever
respiratori
syndrom
frequent
hcov
singl
infect
p
conclus
use
multipl
primer
set
target
differ
gene
recommend
diagnosi
type
hcov
infect
addit
detect
still
untyp
hcov
strain
suggest
number
hcov
involv
human
patholog
might
increas
final
hcov
screen
routin
infant
immunocompromis
patient
acut
respiratori
infect
winterspr
season
patient
acut
respiratori
infect
associ
human
coronaviru
hcov
strain
identifi
among
immunocompet
immunocompromis
patient
admit
hospit
acut
respiratori
syndrom
viral
infect
diagnos
either
immunolog
monoclon
antibodi
molecular
rtpcr
method
two
set
primer
pair
develop
detect
cov
pancov
fail
detect
hcov
strain
identifi
hand
hcov
strain
could
detect
use
typespecif
primer
target
gene
n
cell
line
found
suscept
isol
identif
strain
overal
hcov
infect
caus
strain
patient
respect
addit
three
patient
infect
untyp
hcov
strain
strain
found
circul
strain
circul
strain
detect
season
monthli
distribut
reach
peak
januari
march
lower
predomin
upper
respiratori
tract
infect
age
group
addit
hcov
infect
interest
immunocompet
infant
young
children
first
year
life
adult
immunocompromis
patient
coinfect
hcov
respiratori
virus
mostli
interest
first
year
life
observ
patient
associ
sever
respiratori
syndrom
frequent
hcov
singl
infect
p
conclus
use
multipl
primer
set
target
differ
gene
recommend
diagnosi
type
hcov
infect
addit
detect
still
untyp
hcov
strain
suggest
number
hcov
involv
human
patholog
might
increas
final
hcov
screen
routin
infant
immunocompromis
patient
acut
respiratori
infect
j
med
virol
wileyliss
inc
follow
first
report
tyrrel
byno
hamr
procknow
mcintosh
et
al
human
coronavirus
hcov
shown
pathogen
volunt
studi
bradburn
somerset
widespread
commun
number
seroepidemiolog
survey
two
known
strain
mcintosh
et
al
kay
et
al
kay
et
al
hamr
beem
monto
lim
gerna
et
al
gerna
et
al
macnaughton
initi
sever
hcov
describ
tyrrel
byno
mcintosh
et
al
howev
virus
could
grown
tissu
cultur
anim
model
attempt
identifi
hcov
clinic
specimen
cell
cultur
use
either
polyclon
monoclon
antibodi
satisfactori
mcintosh
et
al
sizun
et
al
anim
cov
investig
extens
varieti
anim
speci
studi
antigen
relationship
human
anim
cov
address
kay
et
al
gerna
et
al
uniqu
strategi
replic
cov
describ
lai
holm
allow
rapid
identif
etiolog
agent
sever
acut
respiratori
syndrom
hcovsar
peiri
et
al
parallel
potenti
pathogen
role
hcov
particular
diseas
gastrointestin
tract
investig
studi
antigen
relationship
neonat
calf
diarrhea
coronaviru
bovin
cov
bcov
human
enter
cov
chani
et
al
gerna
et
al
addit
molecular
techniqu
permit
identif
known
group
group
ii
hcov
respiratori
secret
sizun
et
al
elsahli
et
al
vabret
et
al
vabret
et
al
falsey
et
al
pene
et
al
vallet
et
al
discoveri
new
hcov
recent
two
group
research
netherland
fouchier
et
al
van
der
hoek
et
al
one
group
usa
esper
et
al
report
new
hcov
refer
new
respect
viru
relat
distantli
describ
one
viral
agent
associ
acut
respiratori
diseas
hospit
children
furthermor
anoth
hcov
refer
distantli
relat
detect
two
hongkong
patient
pneumonia
woo
et
al
report
elsewher
woo
et
al
sloot
et
al
vabret
et
al
similar
viru
also
report
sweden
molecular
screen
respiratori
tract
sampl
alland
et
al
final
studi
address
circul
hcov
respect
respiratori
virus
differ
countri
well
involv
respiratori
syndrom
common
cold
associ
asthma
chronic
obstruct
bronchopneumopathi
includ
hcov
pneumonia
transplant
patient
lina
et
al
folz
elkordi
elsahli
et
al
falsey
et
al
present
sever
issu
remain
investig
defin
reliabl
current
avail
immunolog
molecular
methodolog
diagnos
infect
caus
differ
group
hcov
ii
epidemiolog
respiratori
infect
caus
hcov
iii
role
known
hcov
caus
admiss
hospit
patient
respiratori
infect
well
relationship
sever
relev
respiratori
syndrom
iv
compar
pathogen
differ
hcov
differ
age
group
present
studi
issu
investig
hospit
patient
popul
affect
infect
two
consecut
winterspr
season
date
detect
itali
decemb
may
nasopharyng
aspir
collect
prospect
patient
admit
hospit
episod
acut
respiratori
infect
less
year
old
year
old
year
old
year
old
studi
patient
subdivid
base
immunocompet
four
age
class
immunocompet
includ
patient
immunosuppress
patient
includ
subject
respect
immunosuppress
patient
includ
first
three
age
group
hematopoiet
stem
cell
transplant
recipi
group
solid
organ
transplant
recipi
stem
cell
transplant
recipi
two
aid
patient
specimen
handl
aliquot
report
previous
use
immunolog
monoclon
antibodi
molecular
rtpcr
assay
well
shortterm
longterm
viru
isol
cell
cultur
respiratori
sampl
examin
routin
influenzavirus
b
parainfluenzavirus
human
respiratori
syncyti
viru
human
adenovirus
direct
fluoresc
stain
cultur
addit
human
metapneumovirus
examin
monoclon
antibodi
rtpcr
recent
report
gerna
et
al
final
hcov
test
monoclon
antibodi
rtpcr
detail
human
rhinovirus
search
rtpcr
steining
et
al
studi
term
coinfect
indic
simultan
detect
two
respiratori
virus
sampl
taken
patient
respiratori
infect
term
sequenti
infect
refer
sequenti
identif
two
differ
respiratori
virus
two
nasopharyng
aspir
taken
patient
within
day
direct
fluoresc
antibodi
stain
appli
slide
contain
smear
respiratori
epitheli
columnar
cell
nasopharyng
aspir
cell
cultur
hr
inocul
respiratori
secret
report
rovida
et
al
either
case
first
step
cell
stain
pool
simulfluor
respiratori
screen
reagent
chemicon
intern
inc
temecula
ca
fluoresceinlabel
monoclon
antibodi
convent
respiratori
virus
influenzaviru
type
b
human
parainfluenzaviru
type
human
respiratori
syncyti
viru
human
adenoviru
second
step
posit
sampl
stain
individu
monoclon
antibodi
obtain
sourc
chemicon
groupand
typespecif
monoclon
human
metapneumoviru
develop
laboratori
report
gerna
et
al
hcov
commerci
avail
monoclon
antibodi
chemicon
found
perform
satisfactorili
monoclon
antibodi
develop
laboratori
found
highli
specif
final
monoclon
antibodi
avail
inocul
cell
cultur
includ
mixtur
mix
ratio
cell
huang
turchek
well
mdck
cell
line
cell
cultur
process
viru
isol
identif
report
previous
rovida
et
al
addit
last
part
studi
nakabayashi
et
al
provid
maura
pizzuti
institut
biomed
research
rome
itali
vero
cell
line
well
secondari
african
green
monkey
kidney
cell
cultur
inocul
six
npa
rtpcrposit
hcov
one
posit
one
posit
four
posit
investig
suscept
cell
isol
propag
hcov
rtpcr
assay
respiratori
virus
optim
detect
least
input
plasmid
copi
describ
previous
addit
report
tabl
npa
test
hcov
rtpcr
use
primer
set
refer
develop
detect
coronavirus
relev
gene
poutanen
et
al
ii
second
set
primer
refer
also
develop
detect
human
anim
coronavirus
relev
gene
iii
three
set
primer
specif
hcov
respect
relev
gene
n
final
three
set
primer
specif
respect
deriv
thu
relev
gene
follow
fragment
gene
amplifi
tabl
nt
amplicon
size
nt
pan
nt
size
nt
pan
nt
size
nt
primer
nt
size
nt
primer
nt
size
nt
primer
addit
follow
fragment
n
gene
amplifi
nt
size
nt
primer
nt
size
nt
primer
nt
size
nt
primer
indic
fragment
gene
n
hcov
follow
amplif
specif
primer
sequenc
abi
prism
automat
sequenc
appli
biosystem
foster
citi
ca
viral
sequenc
amplifi
fragment
gene
n
differ
hcov
strain
well
refer
strain
align
clustal
w
program
version
distanc
pair
nucleotid
sequenc
calcul
use
dnadist
modul
kimura
twoparamet
method
phylip
packag
version
felsenstein
depart
genet
univers
washington
seattl
wa
phylip
njplot
program
use
construct
phylogenet
tree
nucleotid
sequenc
mean
neighborjoin
method
distanc
matric
bootstrap
support
determin
resampl
sequenc
comparison
distribut
frequenc
perform
pearson
chi
squar
test
whole
hcov
strain
identifi
patient
admit
hospit
follow
strain
strain
strain
untyp
hcov
strain
fig
six
strain
four
two
strain
recov
twice
patient
within
week
initi
viru
recoveri
hcovposit
sampl
test
two
set
primer
aim
detect
hcov
strain
tabl
poutanen
et
al
ii
hcovposit
sampl
found
posit
assay
detect
fig
c
nine
strain
detect
primer
pair
conclus
sampl
test
posit
hcov
strain
three
untyp
strain
strain
neg
similarli
sampl
test
posit
strain
strain
neg
untyp
strain
primer
set
hcov
strain
type
sequenc
phylogenet
analysi
use
amplif
product
provid
either
pancov
subsequ
confirm
result
hcov
strain
amplifi
use
two
primer
pair
specif
gene
n
prototyp
respect
tabl
pancov
type
result
consist
confirm
typespecif
primer
set
crossreact
among
primer
primerspecif
amplif
product
gene
fig
n
fragment
use
phylogenet
analysi
strain
cluster
group
distinct
refer
strain
much
distant
new
hcov
except
singl
strain
ipv
distinct
similarli
cluster
singl
group
distinct
refer
strain
distant
final
strain
group
togeth
substanti
distinct
refer
strain
distant
summari
genet
variabl
nt
aa
chang
differ
hcov
strain
within
limit
amplifi
fragment
gene
n
respect
refer
strain
report
gene
bank
given
tabl
ii
weak
amplif
three
untyp
strain
allow
sequenc
howev
neg
result
follow
amplif
n
gene
primer
exclud
similar
refer
strain
follow
identif
hcovposit
nasopharyng
aspir
rtpcr
retrospect
attempt
made
grow
shortterm
strain
cell
cultur
small
number
specimen
one
one
strain
inocul
found
grow
cell
line
virus
identifi
fig
strain
tcid
ml
crossreact
strain
human
respiratori
virus
detect
either
use
rtpcr
monoclon
antibodi
hand
four
sampl
show
initi
growth
secondari
african
green
monkey
kidney
cell
cultur
well
vero
cell
line
indic
rtpcr
use
typespecif
primer
fig
howev
propag
unsuccess
preliminari
result
suggest
possibl
recoveri
longterm
propag
hcov
strain
cell
cultur
wherea
cell
cultur
system
suitabl
longterm
propag
strain
remain
identifi
among
patient
admit
hospit
episod
acut
respiratori
tract
infect
winterspr
season
patient
found
affect
hcov
infect
list
respiratori
virus
associ
acut
respiratori
infect
patient
report
tabl
iii
frequent
detect
viru
hrsv
follow
rhinovirus
influenza
virus
hmpv
hcov
circul
compar
rate
respect
great
variat
circul
differ
hcov
observ
two
season
examin
fact
strain
circul
infect
patient
strain
infect
patient
strain
detect
season
therebi
infect
patient
fig
b
peak
circul
hcov
reach
januari
march
strain
observ
novemb
may
stratif
age
show
patient
affect
hcov
infect
first
year
life
affect
year
old
group
year
old
group
year
old
fig
patient
respiratori
infect
attribut
singl
hcov
strain
patient
hcov
associ
one
respiratori
virus
analysi
distribut
singl
infect
coinfect
age
show
affect
equal
number
n
patient
first
year
life
incid
coinfect
tabl
iv
greatli
decreas
age
group
four
patient
year
old
group
among
patient
affect
respiratori
viral
infect
associ
hcov
show
lower
bronchiti
bronchiol
pneumonia
upper
respiratori
tract
rhiniti
pharyng
laryng
infect
predomin
lower
versu
upper
infect
observ
patient
age
group
signific
differ
incid
among
differ
age
group
fig
shown
figur
mean
percentag
immunocompet
patient
hcov
infect
wherea
mean
percentag
immunocompromis
patient
infect
hcov
statist
signific
differ
w
test
p
rel
risk
contract
hcov
infect
immunocompromis
patient
twice
immunocompet
patient
total
number
hcov
infect
observ
first
year
life
includ
immunocompet
infant
young
children
proport
immunocompet
children
hcov
infect
older
age
group
includ
patient
year
old
group
respect
hcov
infect
observ
immunocompet
patient
older
year
fig
convers
immunocompromis
patient
hcov
infect
observ
first
year
life
patient
older
age
group
hcov
infect
immunocompromis
patient
increas
progress
patient
year
old
group
patient
year
old
group
includ
infect
patient
older
year
patient
fig
group
patient
examin
hcov
respiratori
infect
infect
strain
six
associ
virus
strain
three
coinfect
two
coinfect
addit
three
patient
infect
untyp
hcov
three
coinfect
signific
differ
circul
differ
hcov
among
differ
age
group
observ
fig
common
symptom
rhinorrhea
fever
cough
patient
similarli
predomin
symptom
rhinorrhea
fever
cough
patient
rhinorrhea
cough
commonli
observ
individu
associ
infrequ
episod
fever
sever
lower
respiratori
tract
syndrom
bronchiol
pneumonia
observ
present
lower
respiratori
tract
infect
associ
hcov
first
year
life
six
three
singl
infect
three
coinfect
associ
strain
two
hcov
untyp
strain
coinfect
one
strain
coinfect
one
strain
coinfect
thu
sever
hcov
infect
first
year
life
appear
mostli
associ
strain
convers
none
five
adult
immunocompromis
adult
patient
lower
respiratori
tract
infect
show
associ
bronchiol
pneumonia
sever
respiratori
syndrom
observ
coinfect
patient
tabl
iv
patient
infect
hcov
alon
p
thu
hcov
coinfect
appear
associ
significantli
higher
number
sever
syndrom
involv
lower
respiratori
tract
clinic
studi
hcov
mostli
abandon
due
either
presum
low
clinic
impact
virus
great
difficulti
encount
isol
identif
renew
interest
trigger
recent
identif
coronaviru
respons
sar
addit
develop
viral
genom
amplif
procedur
provid
major
contribut
identif
hcov
infect
major
variant
group
hcov
viru
prototyp
identifi
strain
detect
netherland
fouchier
et
al
van
der
hoek
et
al
usa
esper
et
al
recent
major
variant
group
ii
hcov
viru
prototyp
first
report
hongkong
woo
et
al
franc
australia
region
china
woo
et
al
sloot
et
al
vabret
et
al
wide
rang
antigen
variabl
report
research
recov
seri
virus
organ
cultur
human
embryon
trachea
mcintosh
et
al
mcintosh
howev
great
deal
controversi
rais
genet
stabil
stjean
et
al
variabl
hcov
strain
genet
variabl
hcov
support
present
studi
show
set
pancov
primer
actual
detect
circul
strain
failur
pancov
primer
set
confirm
use
groupspecif
primer
pair
relev
two
differ
gene
similar
conclus
recent
report
anoth
studi
chiu
et
al
result
order
detect
maxim
number
circul
hcov
specif
primer
use
result
confirm
second
set
primer
prefer
target
differ
gene
present
studi
strain
detect
two
pancov
primer
set
use
absenc
posit
control
primer
use
complement
molecular
techniqu
avail
detect
hcov
repres
use
cell
line
recent
employ
respiratori
viru
isol
vabret
et
al
pene
et
al
freymuth
et
al
cell
line
shown
suscept
infect
murin
coronaviru
mous
hepat
viru
koetter
et
al
found
help
increas
rate
respiratori
viru
recoveri
dfaneg
sampl
addit
report
permiss
growth
hcov
rhinovirus
enterovirus
howev
studi
hcov
cultur
day
identifi
rtpcr
present
studi
possibl
isol
extens
propag
two
strain
strain
respiratori
secret
thu
obtain
high
viru
yield
passag
major
morpholog
characterist
strain
presenc
syncyti
format
inocul
cell
cultur
appear
earli
hr
inocul
progress
enlarg
detach
cell
surfac
respect
seem
import
recal
sarshcov
report
produc
syncytia
vivo
ksiazek
et
al
strain
initi
growth
confirm
posit
rtpcr
result
supernat
three
type
cell
cultur
inocul
four
respiratori
sampl
two
cell
line
vero
one
secondari
cultur
african
green
monkey
kidney
howev
subsequ
passag
presenc
viral
rna
signal
medium
weaken
progress
final
disappear
sinc
inocul
sampl
freezethaw
prior
inocul
new
isol
attempt
made
soon
fresh
posit
specimen
becom
avail
phylogenet
analysi
base
sequenc
small
fragment
gene
n
show
three
group
hcov
detect
studi
belong
singl
cluster
clearli
distinct
relev
refer
strain
except
regard
strain
ipv
distinct
pavia
strain
refer
strain
recov
patient
recent
arriv
albani
data
confirm
genet
similar
strain
circul
geograph
area
without
exclud
simultan
presenc
unrel
poorli
relat
strain
patholog
impact
hcov
infect
investig
analyz
role
infect
context
patient
popul
admit
hospit
due
acut
respiratori
infect
two
consecut
winterspr
season
whole
overal
rate
hcov
infect
includ
singl
infect
coinfect
follow
human
respiratori
syncyti
viru
rhinoviru
influenza
viru
infect
preced
human
metapneumovirus
adenovirus
human
parainfluenza
virus
compar
rate
coinfect
sequenti
infect
although
differ
studi
report
variat
data
correl
grossli
previou
survey
lina
et
al
freymuth
et
al
addit
coinfect
differ
respiratori
virus
repeatedli
report
elsahli
et
al
rovida
et
al
epidemiolog
standpoint
great
major
studi
van
der
hoek
et
al
outbreak
found
occur
winterspr
season
recurr
everi
year
mcintosh
et
al
kay
et
al
monto
lim
studi
peak
hcov
circul
reach
januari
march
three
hcov
found
circul
differ
two
consecut
season
studi
strain
found
circul
season
strain
detect
either
one
two
season
observ
previous
other
hand
three
hcov
repres
four
age
group
hospit
patient
popul
divid
report
previous
elsahli
et
al
vabret
et
al
studi
age
distribut
show
larg
predomin
hcov
infect
first
year
life
patient
affect
lower
respiratori
tract
infect
suffer
sever
lower
respiratori
tract
syndrom
bronchiol
pneumonia
import
emphas
infect
infant
young
children
immunocompet
subject
result
strengthen
previou
observ
great
patholog
potenti
hcov
young
patient
mcintosh
et
al
sizun
et
al
elsahli
et
al
vabret
et
al
chiu
et
al
addit
strain
also
newli
identifi
strain
shown
associ
lower
respiratori
tract
infect
includ
bronchiol
pneumonia
arden
et
al
bastien
et
al
ebihara
et
al
esper
et
al
vabret
et
al
therefor
hcov
result
studi
particularli
strain
appear
behav
like
respiratori
virus
human
respiratori
syncyti
viru
human
metapneumoviru
human
parainfluenza
virus
display
greater
virul
infanc
earli
childhood
hand
adult
patient
includ
studi
immunocompromis
transplant
patient
never
suffer
sever
respiratori
syndrom
howev
case
report
hcovrel
pneumonia
describ
pene
et
al
increas
number
transplant
patient
undergo
immunosuppress
therapi
render
investig
virus
mandatori
lower
respiratori
tract
secret
transplant
recipi
bronchiol
pneumonia
final
significantli
greater
associ
hcov
coinfect
sever
clinic
syndrom
emerg
present
studi
show
rate
sever
lower
respiratori
tract
infect
greater
patient
coinfect
compar
less
patient
singl
infect
major
patholog
effect
hcov
coinfect
observ
infant
young
children
howev
whether
coinfect
hcov
factor
increas
sever
associ
viral
infect
remain
hypothet
conclus
genet
variabl
hcov
might
make
detect
circul
strain
difficult
cultur
might
import
new
hcov
detect
recent
renew
interest
hcov
allow
identif
virus
major
pathogen
infanc
earli
childhood
patholog
role
immunocompromis
patient
remain
defin
coinfect
hcov
respiratori
virus
often
detect
sever
lower
respiratori
tract
infect
infant
young
children
